XPH icon

SPDR S&P Pharmaceuticals ETF
XPH

Overview Fund Activity

74 hedge funds and large institutions have $286M invested in SPDR S&P Pharmaceuticals ETF in 2014 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 28 increasing their positions, 18 reducing their positions, and 6 closing their positions.

Holders
74
Holders Change
+5
Holders Change %
+7.25%
% of All Funds
2.15%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
11
Increased
28
Reduced
18
Closed
6
Calls
$445K
Puts
$424K
Net Calls
+$21K
Net Calls Change
-$197K

Top Buyers

1
U
1
UBS
Switzerland
$37.3M
2
CA
2
Cumberland Advisors
Florida
$4.33M
3
CS
3
Credit Suisse
Switzerland
$2.47M
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$1.38M
5
Wells Fargo
5
Wells Fargo
California
$10.9M

Top Sellers

1
Goldman Sachs
1
Goldman Sachs
New York
$16.4M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$0
3
AP
3
Advisors Preferred
Maryland
$331K
4
NCM
4
Niemann Capital Management
Nevada
$10.3M
5
PG
5
PEAK6 Group
Illinois
$0
Name Market Value Shares Shares
Change 		Shares
Change %
PG
76
PEAK6 Group
Illinois
– – -6,550 Closed
Jane Street
77
Jane Street
New York
– – -4,165 Closed
CC
78
Columbia Capital
California
– – -3,012 Closed
Bank of Montreal
79
Bank of Montreal
Ontario, Canada
– – -700 Closed
W
80
Wealthfront
California
– – -12 Closed
1 2 3
4